Current status of ureteral stent technologies: Comfort and antimicrobial resistance

Current Urology Reports

Volumn 11, Issue 2, 2010, Pages 67-73

  Mendez Probst, Carlos E ^a   Fernandez, Alfonso ^a   Denstedt, John D ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

Stent associated infections; Symptoms; Ureteral stent

Indexed keywords

ALFUZOSIN; BIOMATERIAL; CODEINE; HEPARIN; KETOROLAC; LIDOCAINE; OXYBUTYNIN; OXYCODONE; PHENAZOPYRIDINE; PLACEBO; POLYURETHAN; ROPIVACAINE; TACHYPLESIN; TAMSULOSIN; TEICOPLANIN; TOLTERODINE; TRICLOSAN;

ANTIBIOTIC RESISTANCE; BACTERIURIA; BIOCOMPATIBILITY; BIOFILM; BIOMECHANICS; CLINICAL TRIAL; DEVICE REMOVAL; DRUG EFFICACY; DRUG ELUTING STENT; DRUG TISSUE LEVEL; EQUIPMENT DESIGN; EXTRACORPOREAL LITHOTRIPSY; FLANK PAIN; HUMAN; INCIDENCE; INFECTION PREVENTION; LOWER URINARY TRACT SYMPTOM; MATERIAL COATING; NEPHROLITHIASIS; NONHUMAN; PREVALENCE; PROSTHESIS INFECTION; REVIEW; URETER STENT; URINARY TRACT INFECTION;

ANTI-INFECTIVE AGENTS; CATHETERS, INDWELLING; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; INCIDENCE; MALE; PAIN; PATIENT SATISFACTION; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; STENTS; URETER; URINARY CATHETERIZATION; URINARY TRACT INFECTIONS;

EID: 77952237636     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-010-0091-y     Document Type: Review

References (57)

1. HB Joshi A Stainthorpe FX Keeley Jr, et al. 2001 Indwelling ureteral stents: evaluation of quality of life to aid outcome analysis J Endourol 15 151 154 10.1089/089277901750134421 1:STN:280:DC%2BD3MvlvF2qtw%3D%3D 11325084 (Pubitemid 32290834)
2. D Leibovici A Cooper A Lindner, et al. 2005 Ureteral stents: morbidity and impact on quality of life Isr Med Assoc J 7 491 494 16106772 (Pubitemid 41102868)
3. GM Lennon JA Thornhill PA Sweeney, et al. 1995 'Firm' versus 'soft' double pigtail ureteric stents: a randomised blind comparative trial Eur Urol 28 1 5 1:STN:280:DyaK287isV2gsg%3D%3D 8521886
4. HB Joshi SV Chitale M Nagarajan, et al. 2005 A prospective randomized single-blind comparison of ureteral stents composed of firm and soft polymer J Urol 174 2303 2306 10.1097/01.ju.0000181815.63998.5f 1:CAS:528: DC%2BD2MXhtF2ns77I 16280829 (Pubitemid 41611810)
5. JL Pryor MJ Langley AD Jenkins 1991 Comparison of symptom characteristics of indwelling ureteral catheters J Urol 145 719 722 1:STN:280: DyaK3M7ntFelug%3D%3D 2005686
6. C Lee M Kuskowski J Premoli, et al. 2005 Randomized evaluation of ureteral stents using validated symptom questionnaire J Endourol 19 990 993 10.1089/end.2005.19.990 16253066 (Pubitemid 41619161)
7. JE Lingeman GM Preminger ER Goldfischer AE Krambeck 2009 Comfort Study Team: Assessing the impact of ureteral stent design on patient comfort J Urol 181 2581 2587 10.1016/j.juro.2009.02.019 19375088
8. Dunn MD, Portis AJ, Kahn SA, et al.: Clinical effectiveness of new stent design: randomized single-blind comparison of tail and double-pigtail stents. J Endourol. 2000, 14:195-202
9. J Lumiaho A Heino T Kauppinen, et al. 2007 Drainage and antireflux characteristics of a biodegradable self-reinforced, self-expanding X-ray-positive poly-L, D-lactide spiral partial ureteral stent: an experimental study J Endourol 21 1559 1564 10.1089/end.2005.0085 18186698
10. E Erturk A Sessions JV Joseph 2003 Impact of ureteral stent diameter on symptoms and tolerability J Endourol 17 59 62 10.1089/08927790360587342 12689395 (Pubitemid 36348877)
11. PS Chandhoke AZ Barqawi C Wernecke RA Chee-Awai 2002 A randomized outcomes trial of ureteral stents for extracorporeal shock wave lithotripsy of solitary kidney or proximal ureteral stones J Urol 167 1981 1983 10.1016/S0022-5347(05)65067-7 11956422 (Pubitemid 34309641)
12. R Damiano R Autorino M De Sio, et al. 2005 Does the size of ureteral stent impact urinary symptoms and quality of life? A prospective randomized study Eur Urol 48 673 678 10.1016/j.eururo.2005.06.006 16039775 (Pubitemid 41278595)
13. AM Al-Kandari TF Al-Shaiji H Shaaban, et al. 2007 Effects of proximal and distal ends of double-J ureteral stent position on postprocedural symptoms and quality of life: a randomized clinical trial J Endourol 21 698 702 10.1089/end.2007.9949 17705753 (Pubitemid 47311409)
14. AR El-Nahas AM El-Assmy AM Shoma, et al. 2006 Self-retaining ureteral stents: analysis of factors responsible for patients' discomfort J Endourol 20 33 37 10.1089/end.2006.20.33 16426130 (Pubitemid 43201617)
15. A Rane A Saleemi D Cahill, et al. 2001 Have stent-related symptoms anything to do with placement technique? J Endourol 15 741 745 10.1089/08927790152596352 1:STN:280:DC%2BD3MnksFGksw%3D%3D 11697408 (Pubitemid 32954386)
16. RD Norris RL Sur WP Springhart, et al. 2008 A prospective, randomized, double- blinded placebo-controlled comparison of extended release oxybutynin versus phenazopyridine for the management of postoperative ureteral stent discomfort Urology 71 792 795 10.1016/j.urology.2007.11.004 18339420
17. R Beddingfield RN Pedro B Hinck, et al. 2009 Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study J Urol 181 170 176 10.1016/j.juro.2008.09.026 19013590
18. C Deliveliotis M Chrisofos E Gougousis, et al. 2006 Is there a role for alpha1- blockers in treating double-J stent-related symptoms? Urology 67 35 39 10.1016/j.urology.2005.07.038 16413328 (Pubitemid 43069251)
19. R Damiano R Autorino M De Sio, et al. 2008 Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study J Endourol 22 651 656 10.1089/end.2007.0257 18338955 (Pubitemid 351550748)
20. • Wang CJ, Huang SW, Chang CH: Effects of specific alpha-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study. Urol Res 2009, 37:147-152. This solid and large randomized clinical trial shows the effect of a superselective α- blocker for stent-related symptoms.
21. DT Beiko JD Watterson BE Knudsen, et al. 2004 Double-blind randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stent symptoms after extracorporeal shockwave lithotripsy J Endourol 18 723 730 15659891
22. RL Sur GE Haleblian DA Cantor, et al. 2008 Efficacy of intravesical ropivacaine injection on urinary symptoms following ureteral stenting: a randomized, controlled study J Endourol 22 473 478 10.1089/end.2007.9847 18290733 (Pubitemid 351430738)
23. Chew B, Davoudi H, Li J, Denstedt JD: An in vivo porcine evaluation of the safety, bioavailability and tissue penetration of ketorolac drug eluting ureteral stent designed to improve comfort. J Endourol 2009 (in press).
24. Krambeck AM, Walsh RS, Denstedt JD, et al.: A novel drug eluting stent: a prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a ketorolac loaded ureteral stent. J Urol 2009 (in press).
25. A Paz GE Amiel N Pick, et al. 2005 Febrile complications following insertion of 100 double-J ureteral stents J Endourol 19 147 150 10.1089/end.2005.19.147 15798408 (Pubitemid 40490453)
26. JW Costerton KJ Cheng GG Geesey, et al. 1987 Bacterial biofilm in nature and disease Ann Rev Microbiol 41 435 464 10.1146/annurev.mi.41.100187.002251 1:CAS:528:DyaL2sXmtlalu70%3D
27. G Reid JD Sobel 1987 Bacterial adherence in the pathogenesis of urinary tract infection: a review Rev Infect Dis 9 470 487 1:STN:280: DyaL2s3mt1yltA%3D%3D 2885910
28. CR Riedl E Plas W Hubner, et al. 1999 Bacterial colonization of ureteral stents Eur Urol 36 53 59 10.1159/000019927 1:STN:280:DyaK1M3psVOhsQ%3D%3D 10364656 (Pubitemid 29265281)
29. F Akai U Aflay A Gedik, et al. 2007 Risk factors for lower urinary tract infection and bacterial stent colonization in patients with a double J ureteral stent Int Urol Nephrol 39 95 98 10.1007/s11255-006-9150-1 (Pubitemid 46722946)
30. R Klis E Korczak-Kozakiewicz A Denys, et al. 2009 Relationship between urinary tract infection and self-retaining double J catheter colonization J Urol 23 1015 1019
31. B Lojanapiwat 2006 Colonization of internal ureteral stent and bacteriuria World J Urol 24 681 683 10.1007/s00345-006-0135-6 1:STN:280:DC%2BD28jisVGjtw%3D%3D 17094007 (Pubitemid 44896710)
32. I Connell W Agace P Klemm, et al. 1996 Type I fimbrial expression enhances Escherichia coli virulence for the urinary tract Proc Natl Acad Sci U S A 93 9827 9832 10.1073/pnas.93.18.9827 1:CAS:528:DyaK28XlsFehtL4%3D 8790416 (Pubitemid 26296694)
33. M Santin A Motta SP Denyer M Cannas 1999 Effect of the urine conditioning film on ureteral stent encrustation and characterization of its protein composition Biomaterials 20 1245 1251 10.1016/S0142-9612(99)00026-5 1:CAS:528:DyaK1MXktVSisL4%3D 10395394 (Pubitemid 29276520)
34. JD Denstedt G Reid M Sofer 2000 Advances in ureteral stent technology World J Urol 18 237 242 10.1007/PL00007074 1:STN:280:DC%2BD3M%2Fjs1Gmtg%3D%3D 11000305
35. G Reid C Tieszer JD Denstedt D Kingston 1995 Examination of bacterial and encrustation deposition on ureteral stents of differing surface properties, after indwelling in humans Coll Surf B Biointerfaces 5 171 179 10.1016/0927-7765(95)01208-Z 1:CAS:528:DyaK2MXpsV2mu74%3D (Pubitemid 26167295)
36. G Reid HJ Busscher 1992 Importance of surface properties in bacterial adhesion to biomaterials, with particular reference to the urinary tract Int Biodeter Biodegrad 30 105 122 10.1016/0964-8305(92)90057-U
37. AG Gristina 1987 Biomaterial-centered infection: microbial adhesion versus tissue integration Science 237 1588 1595 10.1126/science.3629258 1:CAS:528:DyaL2sXls1WntLw%3D 3629258
38. Characklis WG, Marshall KC: Biofilms: a basis for interdisciplinary approach. In Biofilms. Edited by Characklis WG, Marshall KC. New York: John Wiley and Sons;1990:3-15.
39. Reid G, Busscher HJ: Microbial biofilms and urinary tract infections. Urinary tract infections. London: Chapman and Hall; 1998:111-118.
40. • Stickler DJ: Bacterial biofilms in patients with indwelling urinary catheters. Nat Clin Pract 2008, 5:598-608. This is a comprehensive review of the mechanisms of biofilm formation.
41. J Salo JJ Devancer T Tapiainen, et al. 2009 Biofilm formation by Escherichia coli isolated from patients with urinary tract infections Clin Nephrol 71 501 507 1:STN:280:DC%2BD1MznsVChsg%3D%3D 19473609
42. F Hasan I Xess X Wang, et al. 2009 Biofilm formation in clinical Candida isolates and its association with virulence Microbes Infect 11 753 761 10.1016/j.micinf.2009.04.018 1:CAS:528:DC%2BD1MXptVSgsLs%3D 19409507
43. R Raad J Darouiche D Dupuis, et al. 1997 Central venous catheters coated with minocycline and rifampin for the prevention of catheter related colonization and bloodstream infections Ann Intern Med 127 267 274 1:CAS:528:DyaK2sXls1ymu7k%3D 9265425
44. PA Cadieux B Chew L Nott, et al. 2009 Use of triclosan-eluting ureteral stents in patients with long-term stents J Endourol 23 1187 1188 10.1089/end.2008.0437 19538062
45. PA Cadieux BH Chew BE Knudsen, et al. 2006 Triclosan loaded ureteral stents decrease Proteus mirabilis 296 infection in a rabbit urinary tract infection model J Urol 175 2331 10.1016/S0022-5347(06)00252-7 16697868 (Pubitemid 43668543)
46. BH Chew PA Cadieux G Reid, et al. 2006 In-vitro activity of triclosan-eluting ureteral stents against common bacterial uropathogens J Endourol 20 949 10.1089/end.2006.20.949 17144870 (Pubitemid 44907031)
47. CN Elwood BH Chew S Seney, et al. 2007 Triclosan inhibits uropathogenic Escherichia coli-stimulated tumor necrosis factor-α secretion in T24 bladder cells in vitro J Endourol 21 1217 1222 10.1089/end.2007.9903 17949329 (Pubitemid 47614367)
48. AH Angell MI Resnick 1989 Surface interaction between glycosaminoglycans and calcium oxalate J Urol 141 1255 1:STN:280:DyaL1M3hslWnsw%3D%3D 2709520
49. P Appelgren U Ransjo L Bindslev, et al. 1996 Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: results from a prospective, randomized trial Crit Care Med 24 1482 10.1097/00003246-199609000-00009 1:STN:280:DyaK28zptVKgsQ%3D%3D 8797619
50. D Lange C Elwood K Choi, et al. 2009 Uropathogen interaction with the surface of urological stents using different surface properties J Urol 182 1194 1200 10.1016/j.juro.2009.05.008 19625060
51. F Cauda V Cauda C Fiori, et al. 2008 Heparin coating on ureteral double J stents prevents encrustations: an in vivo case study J Endourol 22 465 472 10.1089/end.2007.0218 18307380 (Pubitemid 351430716)
52. RE Hancock MG Scott 2000 The role of antimicrobial peptides in animal defenses Proc Natl Acad Sci U S A 97 8856 8861 10.1073/pnas.97.16.8856 1:CAS:528:DC%2BD3cXls12ltLg%3D 10922046 (Pubitemid 30626637)
53. D Minardi R Ghiselli O Cirioni, et al. 2007 The antimicrobial tachyplesin III coated alone and in combination with intraperitoneal piperacillin- tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model Peptides 28 2293 2298 10.1016/j.peptides.2007.10.001 1:CAS:528:DC%2BD2sXhtlCqsrrN 18022289 (Pubitemid 350116312)
54. N Balaban Y Gov A Bitler JR Boelaert 2003 Prevention of staphylococcus aureus biofilm on dialysis catheters and adherence to human cells Kidney Int 63 340 345 10.1046/j.1523-1755.2003.00733.x 12472801 (Pubitemid 35463939)
55. O Cirioni R Ghiselli D Minardi, et al. 2007 RNAIII-Inhibiting peptide affects biofilm formation in a rat model of staphylococcal ureteral stent infection Antimicrob Agents Chemother 51 4518 4520 10.1128/AAC.00808-07 1:CAS:528:DC%2BD2sXhsVWisbbM 17875996 (Pubitemid 350209919)
56. N Laube L Kleinen J Bradenhal A Meissner 2007 Diamond-like carbon coatings on ureteral stents: a new strategy for decreasing the formation of crystalline bacterial biofilms? J Urol 177 1923 1927 10.1016/j.juro.2007.01.016 1:CAS:528:DC%2BD2sXlsV2jtbk%3D 17437849 (Pubitemid 46578223)
57. JD Denstedt PA Cadieux 2009 Eliminating biofilm from ureteric stents: the holy grail Curr Op Urol 19 205 210 10.1097/MOU.0b013e328323d6d2